G. Remuzzi

Publications1,633
h-index163
Citations128,509
Highly Influential Citations3,290
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • N. Perico
  • 407 Publications • 37,148 Citations
  • P. Ruggenenti
  • 383 Publications • 22,136 Citations
  • A. Benigni
  • 373 Publications • 17,994 Citations
  • M. Noris
  • 256 Publications • 15,284 Citations
  • Publications
  • Influence
Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype.
BACKGROUND AND OBJECTIVES Hemolytic uremic syndrome (HUS) is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and renal impairment. Most childhood cases are caused by Shiga… Expand
COVID-19 and Italy: what next?
Summary The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has already taken on pandemic proportions, affecting over 100 countries in a matter of weeks. A global response… Expand
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.
BACKGROUND Diabetic nephropathy is the leading cause of end-stage renal disease. Interruption of the renin-angiotensin system slows the progression of renal disease in patients with type 1 diabetes,… Expand
von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
BACKGROUND Thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome are severe microvascular disorders of platelet clumping with similar signs and symptoms. Unusually large multimers of… Expand
Delayed graft function in kidney transplantation
Delayed graft function is a form of acute renal failure resulting in post-transplantation oliguria, increased allograft immunogenicity and risk of acute rejection episodes, and decreased long-term… Expand
Atypical hemolytic-uremic syndrome.
The hemolytic–uremic syndrome, which is characterized by nonimmune hemolytic anemia, thrombocytopenia, and renal impairment, occurs most frequently in young children. Most cases are secondary to… Expand
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.
BACKGROUND Statins reduce the incidence of cardiovascular events in patients at high cardiovascular risk. However, a benefit of statins in such patients who are undergoing hemodialysis has not been… Expand
The contribution of chronic kidney disease to the global burden of major noncommunicable diseases.
Noncommunicable diseases (NCDs) are the most common causes of premature death and morbidity and have a major impact on health-care costs, productivity, and growth. Cardiovascular disease, cancer,… Expand
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological…
BACKGROUND The Global Burden of Disease Study 2013 (GBD 2013) aims to bring together all available epidemiological data using a coherent measurement framework, standardised estimation methods, and… Expand
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.
BACKGROUND Atypical hemolytic-uremic syndrome is a genetic, life-threatening, chronic disease of complement-mediated thrombotic microangiopathy. Plasma exchange or infusion may transiently maintain… Expand
...
1
2
3
4
5
...